DIANE BRODERICK: Open Payments
NPI 1699746792 · AMSTERDAM, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$778 in 8 payments from 7 companies in 2025. Trend: 2023 $843 · 2024 $709 · 2025 $778
Food & beverage: $778
| Company | Payments | Amount |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $210 |
| Madrigal Pharmaceuticals | 1 | $135 |
| CVRx, Inc. | 1 | $104 |
| ABBVIE INC. | 1 | $97 |
| ABIOMED | 1 | $93 |
| Axsome Therapeutics, Inc. | 1 | $82 |
| ALK-Abello, Inc | 1 | $56 |
Products named: REZDIFFRA, Barostim Neo System, QULIPTA, Auvelity.
Industry payments across NY — which companies pay providers there.
